Integration of HIV testing in tuberculosis drug resistance surveillance in Kazakhstan and Kenya

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 5, 2012, Pages 615-617

  Klinkenberg, Eveline ^a,b   Van Den Hof, S ^a,b   Tursynbayeva, A ^c   Kipruto, H ^d,e   Wahogo, J ^d   Pak, S ^a   Kutwa, A ^a   L'Herminez, R ^a  

^a KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Ministry of Health of the Republic of Kazakhstan   (Kazakhstan)

^d Ministry of Public Health and Sanitation   (Kenya)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Drug resistance; HIV; Kazakhstan; Kenya; TB

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; RIFAMPICIN;

ARTICLE; DISEASE ASSOCIATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAZAKHSTAN; KENYA; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RELAPSE; VALIDATION PROCESS;

ADULT; ANTITUBERCULAR AGENTS; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HUMANS; KAZAKHSTAN; KENYA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POPULATION SURVEILLANCE; PROGRAM DEVELOPMENT; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84859729573     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0262     Document Type: Article

References (5)

1. Wells C D, Cegielski J P, Nelson L J, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007; 196 (Suppl 1): S86-S107. (Pubitemid 47206088)
2. Suchindran S, Brouwer E S, Van Rie A. Is HIV infection a risk factor for multidrug-resistant tuberculosis? A systematic review. PLoS ONE 2009; 4: e5561.
3. World Health Organization. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Antituberculosis drug resistance in the world. Third global report. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004.
4. World Health Organization. Global tuberculosis control 2009: epidemiology, strategy, financing. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.
5. Zignol M, van Gemert W, Falzon D, Jaramillo E, Blanc L, Raviglione M. Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis 2011; 52: 901-906.